BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10584880)

  • 1. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.
    Axdorph U; Porwit-MacDonald A; Sjöberg J; Grimfors G; Ekman M; Wang W; Biberfeld P; Björkholm M
    Br J Cancer; 1999 Dec; 81(7):1182-7. PubMed ID: 10584880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
    Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
    Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
    Almasri NM; Khalidi HS
    Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
    Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
    Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
    Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
    Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
    Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
    J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
    Quintanilla-Martínez L; Gamboa-Domínguez A; Gámez-Ledesma I; Orozco-Estévez H; Angeles-Angeles A
    Rev Invest Clin; 1994; 46(5):355-62. PubMed ID: 7839015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of association of Epstein Barr-virus with Hodgkin's disease.
    Radha K; Shanthi P; Madhavan M; Senthamarai A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Assis MG; Eiras DP; Dobo C; Oliveira JS
    Hematol Oncol; 2010 Sep; 28(3):137-41. PubMed ID: 20128016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
    J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
    Sleckman BG; Mauch PM; Ambinder RF; Mann R; Pinkus GS; Kadin ME; Sherburne B; Perez-Atayde A; Thior I; Mueller N
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1117-21. PubMed ID: 9865430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin's lymphoma.
    Lacroix A; Jaccard A; Rouzioux C; Piguet C; Petit B; Bordessoule D; Ranger-Rogez S
    J Med Virol; 2007 Sep; 79(9):1349-56. PubMed ID: 17607791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nodular paragranuloma and Epstein-Barr virus: frequency of EBV DNA and clinical relevance].
    Rohde D; Niedermeyer H; Fellbaum C; Hansmann ML; Busch R; Lauder I; Höfler H; Fischer R
    Verh Dtsch Ges Pathol; 1992; 76():177-80. PubMed ID: 1283254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
    Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.